m-Chlorophenylbiguanide hydrochloridePotent and specific 5-HT3 agonist CAS# 2113-05-5 |
2D Structure
- Ampalex
Catalog No.:BCC1359
CAS No.:154235-83-3
- Tezampanel
Catalog No.:BCC1993
CAS No.:154652-83-2
- Noopept
Catalog No.:BCC1804
CAS No.:157115-85-0
- Perampanel
Catalog No.:BCC1847
CAS No.:380917-97-5
- Aniracetam
Catalog No.:BCC4219
CAS No.:72432-10-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 2113-05-5 | SDF | Download SDF |
PubChem ID | 2730228 | Appearance | Powder |
Formula | C8H11Cl2N5 | M.Wt | 248.11 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water | ||
Chemical Name | 2-(3-chlorophenyl)-1-(diaminomethylidene)guanidine;hydrochloride | ||
SMILES | C1=CC(=CC(=C1)Cl)N=C(N)N=C(N)N.Cl | ||
Standard InChIKey | FOWAIJYHRWFTHR-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H10ClN5.ClH/c9-5-2-1-3-6(4-5)13-8(12)14-7(10)11;/h1-4H,(H6,10,11,12,13,14);1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Prototypical potent and selective 5-HT3 receptor agonist. |
m-Chlorophenylbiguanide hydrochloride Dilution Calculator
m-Chlorophenylbiguanide hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0305 mL | 20.1524 mL | 40.3047 mL | 80.6094 mL | 100.7618 mL |
5 mM | 0.8061 mL | 4.0305 mL | 8.0609 mL | 16.1219 mL | 20.1524 mL |
10 mM | 0.403 mL | 2.0152 mL | 4.0305 mL | 8.0609 mL | 10.0762 mL |
50 mM | 0.0806 mL | 0.403 mL | 0.8061 mL | 1.6122 mL | 2.0152 mL |
100 mM | 0.0403 mL | 0.2015 mL | 0.403 mL | 0.8061 mL | 1.0076 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 9,17-Octadecadiene-12,14-diyne-1,11,16-triol
Catalog No.:BCN1497
CAS No.:211238-60-7
- Rubranol
Catalog No.:BCN4917
CAS No.:211126-61-3
- Sobetirome
Catalog No.:BCC1957
CAS No.:211110-63-3
- Marsformoxide B
Catalog No.:BCN6687
CAS No.:2111-46-8
- SB 265610
Catalog No.:BCC5936
CAS No.:211096-49-0
- Mahanimbine
Catalog No.:BCN3174
CAS No.:21104-28-9
- BMY 7378
Catalog No.:BCC5063
CAS No.:21102-95-4
- CART (62-76) (rat, human)
Catalog No.:BCC6008
CAS No.:210978-19-1
- W-84 dibromide
Catalog No.:BCC6682
CAS No.:21093-51-6
- Org 12962 hydrochloride
Catalog No.:BCC7718
CAS No.:210821-63-9
- Sakakin
Catalog No.:BCN4916
CAS No.:21082-33-7
- CP 471474
Catalog No.:BCC2373
CAS No.:210755-45-6
- R18
Catalog No.:BCC2383
CAS No.:211364-78-2
- Astrocasine
Catalog No.:BCN2150
CAS No.:2114-92-3
- Dendrobine
Catalog No.:BCN5923
CAS No.:2115-91-5
- Dalcetrapib (JTT-705, RO4607381)
Catalog No.:BCC2328
CAS No.:211513-37-0
- WHI-P154
Catalog No.:BCC2202
CAS No.:211555-04-3
- WHI-P97
Catalog No.:BCC2056
CAS No.:211555-05-4
- WHI-P180
Catalog No.:BCC3928
CAS No.:211555-08-7
- Nudicaucin B
Catalog No.:BCN7843
CAS No.:211557-36-7
- Picroside IV
Catalog No.:BCN6533
CAS No.:211567-04-3
- 2',4',5'-Trimethoxy-2'',2''-dimethylpyrano[5'',6'':6,7]isoflavone
Catalog No.:BCN1496
CAS No.:211799-56-3
- Nudicaucin A
Catalog No.:BCN7842
CAS No.:211815-97-3
- Flumorph
Catalog No.:BCC5467
CAS No.:211867-47-9
Synergistic effect between prelimbic 5-HT3 and CB1 receptors on memory consolidation deficit in adult male Sprague-Dawley rats: An isobologram analysis.[Pubmed:26701293]
Neuroscience. 2016 Mar 11;317:173-83.
The serotonergic system has often been defined as a neuromodulator system, and is specifically involved in learning and memory via its various receptors. Serotonin is involved in many of the same processes affected by cannabinoids. The present study investigated the influence of bilateral post-training intra-prelimbic (PL) administrations of serotonergic 5-hydroxytryptamine type-3 (5-HT3) receptor agents on arachidonylcyclopropylamide (ACPA) (cannabinoid CB1 receptor agonist)-induced amnesia, using the step-through inhibitory avoidance (IA) task to assess memory in adult male Sprague-Dawley rats. The results indicated that sole intra-PL microinjection of ACPA (0.1 and 0.5 mug/rat) and 5-HT3 serotonin receptor agonist (m-Chlorophenylbiguanide hydrochloride, m-CPBG; 0.001, 0.01 and 0.1 mug/rat) impaired, whereas Y-25130 (a selective 5-HT3 serotonin receptor antagonist; 0.001 and 0.01 and 0.1 mug/rat) did not alter IA memory consolidation, by itself. Moreover, intra-PL administration of subthreshold dose of m-CPBG (0.0005 mug/rat) potentiated, while Y-25130 (0. 1 mug/rat) restored ACPA-induced memory consolidation deficit. The isobologram analysis showed that there is a synergistic effect between ACPA and m-CPBG on memory consolidation deficit. These findings suggest that 5-HT3 receptor mechanism(s), at least partly, play(s) a role in modulating the effect of ACPA on memory consolidation in the PL area.
Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.[Pubmed:9517385]
Br J Pharmacol. 1998 Feb;123(4):661-6.
1. Whole cell voltage clamp electrophysiology and radioligand binding were used to examine the agonist characteristics of the two splice variants of the 5-HT3 receptor which have been cloned from neuronal cell lines. Homo-oligomeric 5-HT3 receptors were examined in HEK 293 cells stably transfected with either long (5-HT3-L) or short (5-HT3-S) receptor subunit DNAs. 2. Functional homo-oligomeric receptors were formed from both subunits, and responses to 5-HT3 receptor agonists (5-hydroxytryptamine (5-HT), 2-methyl 5-HT and m-chlorophenylbiguanide) were qualitatively similar. 3. Maximum currents (Rmax) elicited by the 5-HT3 receptor agonists m-chlorophenylbiguanide (mCPBG) and 2-methyl-5-HT (2-Me-5-HT), as compared to 5-HT, differed in the two splice variants: Rmax mCPBG/Rmax 5-HT values were 0.68+/-0.04 and 0.91+/-0.01 in 5-HT3-L and 5-HT3-S receptors, respectively. Comparable values for 2-Me-5-HT were 0.30+/-0.02 and 0.23+/-0.02. 4. Radioligand binding data showed no difference in affinity of agonist or antagonist binding sites; thus the six amino acid deletion appears to cause differences in agonist efficacy. 5. The role of the 6 amino acid insertion was further investigated by use of site-directed mutagenesis to create two mutant receptors, one where serine 286 was replaced with alanine, and the second where all 6 amino acids were replaced with alanines. 6. Examination of the mutant receptors when stably expressed in HEK 293 cells revealed agonist properties resembling long and not short 5-HT3 receptors. Thus specific amino acids in this region are not responsible for the observed differences. 7. The data show intracellular structure can have significant effects on ligand-gated ion channel function, and suggest that minor changes in structure may be responsible for differences in function observed when ligand-gated ion channel proteins are modulated intracellularly.
5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.[Pubmed:1407396]
Neuropharmacology. 1992 Jun;31(6):561-4.
The effect of the novel agonist, 1-(m-chlorophenyl)-biguanide (mCPBG) was examined on 5-HT3 receptors in NG108-15 mouse neuroblastoma x rat glioma hybrid cells, using whole-cell voltage-clamp and radioligand binding on intact cells. Electrophysiological studies showed that mCPBG is a partial agonist, with an EC50 of 3.1 microM. Displacement of the selective 5-HT3 receptor antagonist [3H]GR65630 by mCPBG revealed a Ki of 14.2 nM. The study suggests that mCPBG may have a high affinity for desensitized 5-HT3 receptors and also revealed some differences between 5-HT3 receptors in NG108-15 and N1E-115 cells.
The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.[Pubmed:1797317]
Br J Pharmacol. 1991 Oct;104(2):536-40.
1. The effects of 5-HT3 selective agonists have been studied in whole-cell voltage-clamped N1E-115 neuroblastoma cells. 2. Application of 5-hydroxytryptamine (5-HT) results in the rapid development of a transient inward current at quasiphysiological membrane potentials. This current can be blocked by the 5-HT3 specific antagonists BRL 43694 and GR67330. 3. Application of 2-methyl-5-HT (2-Me5-HT), a 5-HT3 selective agonist, produced a qualitatively similar inward current, but with a maximum response only 20% of that produced by 5-HT. 4. In the presence of 100 microM 2-Me5-HT, the upper part of the 5-HT dose-response curve was shifted to the right but reached the same maximum value as in the absence of 2-Me5-HT. 2-Me5-HT appears therefore to be a partial agonist under these conditions. 5. The novel 5-HT3 agonist, meta-chlorophenylbiguanide (mCPBG) is a full agonist, but has a Hill coefficient (1.5) significantly less than that of 5-HT (2.3). 6. Comparison with radioligand binding data show that mCBPG is 100 times less potent than expected; it may therefore exhibit a high affinity for a desensitized state.
1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.[Pubmed:2144822]
Eur J Pharmacol. 1990 Jun 21;182(1):193-7.
1-(m-Chlorophenyl)-biguanide (mCPBG) was examined and compared with three 5-HT3 receptor agonists in three 5-HT3 receptor models. mCPBG inhibited [3H]GR67330 binding to 5-HT3 receptors with high affinity (IC50 1.5 nM). mCPBG depolarized the rat vagus nerve with an EC50 one tenth of that for 5-HT (0.05 vs. 0.46 microM); the maximum depolarization was approximately half that for 5-HT. The mCPBG depolarization was potently blocked by the selective 5-HT3 antagonist, ondansetron (pKB 8.6 +/- 0.1). In anaesthetised cats, mCPBG potently evoked the Bezold-Jarisch reflex which was blocked by low doses of ondansetron (10 micrograms/kg i.v.). It is concluded that mCPBG is a potent, high affinity 5-HT3 receptor agonist.